Skip to main content

Advertisement

Table 2 Biochemistry analyses in diabetic patients with acute hyperglycemia (Group A) at baseline (upon hospital admission), second (after euglycemia was achieved, 72 h) and third examination (after 3 months), in diabetic patients with euglycemia (Group B) and in healthy controls (Group C)

From: Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography

  Group A p value* Group B Group C p value**
Upon hospital admission Second examination Third examination
Blood glucose (mmol/l) 22.5 ± 1.1a 5.5 ± 0.1 7.2 ± 0.2  < 0.001 5.8 ± 0.2 5.1 ± 0.1  < 0.001
HbA1c (%) 11.5 ± 0.3 NA 7.9 ± 0.2  < 0.001 6.1 ± 0.1 5.0 ± 0.1  < 0.001
Total Ch (mmol/l) 6.2 ± 0.4 5.4 ± 0.2 5.1 ± 0.2 0.002 4.8 ± 0.2 5.1 ± 0.2 0.055
HDL-Ch (mmol/l) 1.2 ± 0.1 1.1 ± 0.1 1.3 ± 0.1 0.053 1.4 ± 0.1 1.6 ± 0.1  < 0.001
LDL-Ch (mmol/l) 2.9 ± 0.2 3.0 ± 0.1 2.8 ± 0.1 0.039 2.7 ± 0.1 2.8 ± 0.2 0.747
Triglyceride (mmol/l) 6.4 ± 1.4 3.2 ± 0.4 2.3 ± 0.2 0.003 1.9 ± 0.2 1.5 ± 0.3 0.036
Troponin (ng/l) 8.9 ± 0.8 6.8 ± 0.5 6.1 ± 0.6 0.013 8.2 ± 0.7 7.6 ± 1.1 0.652
NT-proBNP (pg/ml) 25.0 (28.5)b 14.0 (17.0) 15.0 (20.0)  < 0.001 21.5 (41.5) 19.0 (25.8) 0.597
  1. Ch cholesterol, NT-proBNP N-terminal pro b-type natriuretic peptide
  2. * p—Repeated measures ANOVA (upon hospital admission, second examination and third examination)
  3. ** p—One way ANOVA between Group A (upon hospital admission), Group B and Group C. Post Hoc Bonferroni test between the groups is described in the text
  4. aData are presented as mean ± SE or as bmedian